ERBB2-induced breast cancer cell invasion has been documented to be caused by the TOM1L1-derived membrane delivery of MT1-MMP, and ERBB2 and TOM1L1 are frequently coamplified in the breast (Chevalier et al., 2016). The gene discussed is MMP14; the disease is breast carcinoma.